|
Issues with the DePuy Pinnacle Hip Implant:
What is it all about?
|
In August of 2010, Johnson & Johnson subsidiary, DePuy Orthopedics, issued a recall of its ASR XL Hip Implant,
while its Pinnacle Hip Implant, a similarly designed product in the DePuy Orthopedics line, failed to receive
such a mandate from its manufacturer. Growing concerns about this implant center on its reliance on a defective
metal on metal design, which has a propensity for loosening of the device components, hip dislocation, implant
failure, and blood metal poisoning.
|
|
While the DePuy Pinnacle Hip Implant has yet to be recalled, high failure rates and patients presenting with
metallosis and other serious side effects and symptoms have resulted in numerous lawsuits targeted at DePuy and
its Pinnacle Hip Replacement Product. The number of lawsuits has even prompted speculation that Federal lawsuits
focused on the
|
|
DePuy Pinnacle Hip Implant may be consolidated into a nationwide multidistrict litigation, or MDL.
While such a consolidation has not yet come to fruition, it is not too early to make a determination as to whether
or not you or someone you know might have a potential case against DePuy Orthopedics pertaining to injuries suffered
from its Pinnacle Hip Implant.
If you or someone you know has experienced Hip Implant dislocation, has suffered a Hip Implant Failure,
has tested positive for blood metal poisoning, or has been the victim of some other kind of Hip Implant
related injury, please contact the attorneys at Sullo & Sullo, LLP to tell us about your case. The qualified
and experienced attorneys at Sullo & Sullo, LLP are eager to learn more about your case.
|
|
|
|
|
|
|
|
|
Free Consultation
|
|
Receive an immediate response to your request.
|
|
|
|
|
|
DePuy Hip Recall: Topics of Interest
|
|
Recent Articles and Publications
|
|
|
|
March 31, 2012
|
|
DePuy Litigation: Statute of Limitations Depuy Lawsuits
|
|
In August of 2010 DePuy Orthopedics, Inc. recalled two of its most popular hip replacement systems—the ASR XL Acetabular and the ASR Hip Resurfacing System. The recall came on the heels of a study which indicated the five-year failure rate of these products was as high as one in every eight patients.
|
|
Full Story
|
|
|
|
|
February 05, 2012
|
|
Recall of Artificial Hip Causes Johnson & Johnson 2012 Earnings Forecast to Dip
|
|
The pharmaceutical giant, Johnson & Johnson, has been given a 2012 earnings forecast which is below the previous estimates present by financial analysts due to the number of DePuy hip replacements which were recalled. In fact, recent reports state Johnson & Johnson takes $3 billion charge for hip recall.
|
|
Full Story
|
|
|
|
|
February 04, 2012
|
|
Taking Charge: A Blueprint for DePuy Hip Implant Recipients to Follow for Successful Recovery
|
|
While the FDA began receiving complaints regarding the failure of hip replacement devices manufactured by DePuy Orthopedics (a subsidiary of Johnson & Johnson) for some time, there was not a DePuy hip extensive recall on the device until August of 2010.
|
|
Full Story
|
|
|
|
No article available
|
|
|
|
|
|